DePuy trauma business divestiture to Biomet

Johnson & Johnson's subsidiary DePuy Orthopaedics, Inc. has entered into an agreement to divest its trauma business to Biomet, Inc. following to Johnson & Johnson's acquisition of Synthes Inc. The divestiture  is expected to close in the second quarter 2012.

Johnson & Johnson was advised as to Swiss law by Pestalozzi on this transaction. The Pestalozzi team was headed by Christoph R. Ramstein (corporate and tax) and Christoph G. Lang (M&A) and comprised among other partners Anne-Catherine Imhoff for real estate.